Oculis Holding AG (OCS) Reports Q2 Loss, Beats Revenue Estimates

分组1 - Oculis Holding AG reported a quarterly loss of $0.59 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.53, and compared to a loss of $0.56 per share a year ago, indicating an earnings surprise of -11.32% [1] - The company posted revenues of $0.32 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 28.54%, and this represents an increase from year-ago revenues of $0.27 million [2] - Oculis Holding AG shares have increased by approximately 3.2% since the beginning of the year, while the S&P 500 has gained 8.7% [3] 分组2 - The earnings outlook for Oculis Holding AG is mixed, with the current consensus EPS estimate for the coming quarter at -$0.54 on revenues of $0.25 million, and for the current fiscal year at -$2.44 on revenues of $0.82 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 42% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]